SOC-DGL: Social Interaction Behavior Inspired Dual Graph Learning Framework for Drug-Target Interaction Identification.

Xiang Zhao, Ruijie Li, Qiao Ning, Shikai Guo, Hui Li, Qian Ma
{"title":"SOC-DGL: Social Interaction Behavior Inspired Dual Graph Learning Framework for Drug-Target Interaction Identification.","authors":"Xiang Zhao, Ruijie Li, Qiao Ning, Shikai Guo, Hui Li, Qian Ma","doi":"10.1109/TCBBIO.2026.3742812","DOIUrl":null,"url":null,"abstract":"<p><p>The identification of drug-target interactions (DTI) is critical for drug discovery and repositioning, as it reveals potential therapeutic uses of existing drugs, accelerating development and reducing costs. However, most existing models focus only on direct similarity in homogeneous graphs, failing to exploit the rich similarity in heterogeneous graphs. To address this gap, inspired by real-world social interaction behaviors, we propose SOC-DGL, which comprises two specialized modules: the Affinity-Driven Graph Learning (ADGL) module, learning global similarity through an affinity-enhanced drug-target graph, and the Equilibrium-Driven Graph Learning (EDGL) module, capturing higher-order similarity by amplifying the influence of even-hop neighbors using an even-polynomial graph filter based on balance theory. This dual approach enables SOC-DGL to effectively capture similarity information across multiple interaction scales within affinity and association matrices. To address the issue of imbalance in DTI datasets, we propose an adjustable Reweighted Loss Function (RLF) that moderates the positive-class compensation weight in weighted binary cross-entropy through an adjustable parameter. Experiments on four benchmark datasets show that SOC-DGL achieves competitive performance under both balanced and imbalanced settings. Moreover, SOC-DGL predicts the top 9 drugs known to bind ABL1, and further analyzes the 10th-ranked drug, which has not been experimentally confirmed to interact with ABL1, providing supporting evidence for its potential binding. The source code is available for academic purposes at https://github.com/Zhaoxiang0422/SOC-DGL.</p>","PeriodicalId":520987,"journal":{"name":"IEEE transactions on computational biology and bioinformatics","volume":"PP ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE transactions on computational biology and bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/TCBBIO.2026.3742812","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The identification of drug-target interactions (DTI) is critical for drug discovery and repositioning, as it reveals potential therapeutic uses of existing drugs, accelerating development and reducing costs. However, most existing models focus only on direct similarity in homogeneous graphs, failing to exploit the rich similarity in heterogeneous graphs. To address this gap, inspired by real-world social interaction behaviors, we propose SOC-DGL, which comprises two specialized modules: the Affinity-Driven Graph Learning (ADGL) module, learning global similarity through an affinity-enhanced drug-target graph, and the Equilibrium-Driven Graph Learning (EDGL) module, capturing higher-order similarity by amplifying the influence of even-hop neighbors using an even-polynomial graph filter based on balance theory. This dual approach enables SOC-DGL to effectively capture similarity information across multiple interaction scales within affinity and association matrices. To address the issue of imbalance in DTI datasets, we propose an adjustable Reweighted Loss Function (RLF) that moderates the positive-class compensation weight in weighted binary cross-entropy through an adjustable parameter. Experiments on four benchmark datasets show that SOC-DGL achieves competitive performance under both balanced and imbalanced settings. Moreover, SOC-DGL predicts the top 9 drugs known to bind ABL1, and further analyzes the 10th-ranked drug, which has not been experimentally confirmed to interact with ABL1, providing supporting evidence for its potential binding. The source code is available for academic purposes at https://github.com/Zhaoxiang0422/SOC-DGL.

社会互动行为启发的药物-靶标相互作用识别对偶图学习框架。
药物-靶标相互作用(DTI)的鉴定对于药物发现和重新定位至关重要,因为它揭示了现有药物的潜在治疗用途,加速了开发并降低了成本。然而,现有的模型大多只关注同构图的直接相似度,未能充分利用异构图的丰富相似度。为了解决这一差距,受现实世界社会互动行为的启发,我们提出了SOC-DGL,它包括两个专门的模块:亲和力驱动图学习(ADGL)模块,通过亲和力增强的药物目标图学习全局相似性;平衡驱动图学习(EDGL)模块,通过使用基于平衡理论的偶多项式图滤波器放大偶跳邻居的影响来捕获高阶相似性。这种双重方法使SOC-DGL能够在亲和和关联矩阵内的多个相互作用尺度上有效地捕获相似性信息。为了解决DTI数据集的不平衡问题,我们提出了一个可调的重加权损失函数(RLF),该函数通过一个可调参数来调节加权二元交叉熵中的正类补偿权重。在四个基准数据集上的实验表明,SOC-DGL在平衡和不平衡设置下都具有竞争力。此外,SOC-DGL预测了已知结合ABL1的前9位药物,并进一步分析了尚未被实验证实与ABL1相互作用的第10位药物,为其潜在的结合提供了支持证据。源代码可从https://github.com/Zhaoxiang0422/SOC-DGL获得,用于学术目的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书